TELA Bio Sees Q1 Sales $18.500M vs $21.277M Est

TELA Bio reported Q1 sales of $18.500 million, falling short of the analyst estimate of $21.277 million. This represents a significant deviation from expectations for the company. The stock is traded under the ticker TELA on NASDAQ.